Common Class A Class of Stock [Axis] Common Class B Kard Scientific [Member] Related Party [Axis] Clinical Studies [Member] Patents [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents Two [Member] Patents Three [Member] Innovative Medical Research Inc [Member] Restricted Stock [Member] Mr. Ehrlich [Member] Related Party Transaction [Axis] Ehrlich Promissory Note C [Member] Ehrlich Promissory Notes A and B [Member] Minimum [Member] Range [Axis] Maximum [Member] 30 Million Common Stock Purchase Agreement [Member] Plan Name [Axis] Aspire Capital Fund Llc [Member] Legal Entity [Axis] April 2015 agreement [Member] Year 2019-2025 [Member] Year 2026 [Member] Year 2027 [Member] Year 2028 [Member] Year 2029 and 2032 [Member] Year 2033 [Member] Year 2034 [Member] Two executive officers [Member] Title of Individual [Axis] Operating Leases - Equipment [Member] Stock Options [Member] Award Type [Axis] 2016 Equity Incentive Plan [Member] On June 30, 2016 [Member] Award Date [Axis] Research and Development Expense [Member] Income Statement Location [Axis] Year 2018 [Member] Federal Drug Administration [Member] Stock purchase agreement [Member] Dr. Arthur Bertolino [Member] On September 1, 2017 [Member] Ms. Jane Harness [Member] Ms. Ponugoti [Member] On June 27, 2016 [Member] On July 18, 2016 [Member] Consultant [Member] On August 1, 2016 [Member] On September 1, 2016 [Member] On September 15, 2016 [Member] Dr. Lang [Member] New 2017 Agreement [Member] New 30 Million Common Stock Purchase Agreement [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Trading Symbol Current Fiscal Year End Date Entity Filer Category Document Type Document Period End Date Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Entity Common Stock, Shares Outstanding Statement [Table] Statement [Line Items] ASSETS Current Assets: Cash Prepaid expenses Security deposits Subscription receivable Total Current Assets Other Assets: Patents - net Equipment -net Deferred offering costs - net Security deposit Total Other Assets Total Assets LIABILITIES AND STOCKHOLDERS? DEFICIENCY Current Liabilities: Accounts payable - (including related party payables of approximately $1,511,000 and 1,506,000, respectively) Accrued expenses - (including related party accruals of approximately $54,000 and $38,000, respectively) Accrued salaries and payroll taxes - (including related party accrued salaries of approximately $2,953,000 and $2,953,000, respectively) Convertible note payable - related party Total Current Liabilities Total Liabilities Commitments and contingencies (Note 7) Stockholders Deficiency Preferred stock, $0.001 par value, 10,000,000 designated shares, no shares issued and outstanding Common Stock, Value Additional paid-in capital Accumulated deficit Treasury Stock, at cost (329,136 shares and 262,080 shares as of September 30, 2017 and June 30, 2017, respectively) Total Stockholders Deficiency Total Liabilities and Stockholders Deficiency Accounts payable, related party payables (in dollars) Accrued expenses, related party accruals (in dollars) Accrued salaries, due to related parties (in dollars) Stockholders' Equity Preferred stock, par value (in dollars per share) Preferred stock, shares designated (in shares) Preferred stock, shares issued (in shares) Preferred stock, shares outstanding (in shares) Common Stock, par value (in dollars per share) Common Stock, shares authorized (in shares) Common Stock, shares issued (in shares) Common Stock, shares outstanding (in shares) Treasury Stock value Condensed Statements Of Operations Revenues Operating expenses: Research and development expenses General and administrative expenses Officers' payroll and payroll tax expenses Professional fees Total operating expenses Loss from operations Other income (expenses) Interest income Interest expense Total other expense - net Loss before provision for income taxes Provision for income taxes Net loss Basic and diluted loss per share Weighted average number of common shares outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Common stock and stock options issued as payment for compensation, services rendered and financing costs Amortization of patent costs Depreciation of equipment Changes in operating assets and liabilities: Prepaid expenses and security deposits Other receivable Accounts payable Accrued expenses Accrued officers' salaries and payroll taxes Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Additions to equipment Patent costs Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Sale of common stock, net of offering costs Purchase of treasury stock Net cash provided by financing activities NET DECREASE IN CASH CASH, BEGINNING OF PERIOD CASH, END OF PERIOD SUPPLEMENTAL DISCLOSURES OF CASH FLOW Cash paid for interest SUPPLEMENTAL DISCLOSURE OF NON-CASH FLOW INVESTING AND FINANCING ACTIVITIES Commitment shares issued as deferred offering costs Reversal of subscription receivable to treasury stock Notes to Financial Statements Note 1 - Basis of Presentation and Nature of Operations Note 2 - Going Concern and Liquidity Note 3 - Significant Accounting Policies and Recent Accounting Pronouncements Note 4 - Patents, net Note 5 - Accrued Expenses Note 6 - Accrued Salaries and Payroll Taxes - Related Parties And Other Note 7 - Commitments and Contingencies Note 8 - Related Party Transactions Note 9 - Convertible Note Payable - Related Party Note 10 - Equity Incentive Plans, Stock-Based Compensation, Exercise of Options and Warrants Outstanding Note 11 - Equity Transactions Note 12 - Subsequent Events Significant Accounting Policies And Recent Accounting Pronouncements Policies Use of Estimates Net Loss Per Share Treasury Stock Accounting for Stock Based Compensation Recent Adopted Accounting Pronouncements Recently Issued Accounting Guidance Significant Accounting Policies And Recent Accounting Pronouncements Tables Schedule of components of stock based compensation related to stock options recognized in the company's statement of operations Patents Net Tables Schedule of patents Accrued Expenses Tables Schedule of accrued expenses Accrued Salaries And Payroll Taxes - Related Parties And Other Tables Schedule of accrued salaries and payroll taxes Commitments And Contingencies Tables Future minimum lease payments required under the non-cancelable operating lease Equity Incentive Plans Stock-based Compensation And Warrants Tables Schedule of stock option activity Valuation assumptions for stock options/warrants and SARs Schedule of Restricted Stock Award Activity Schedule of vesting outstanding restricted stock Basis Of Presentation And Nature Of Operations Details Narrative State of incorporation Date of incorporation Cash and cash equivalents Net cash used in operating activities Working capital (deficit) Current liabilities Related parties liabilities Total Expenditure for planned Shares reserved for future issuance under agreement, Value Share reserved for future issuance, Value cancelled Common stock purchase agreement share Additional proceeds from common stock purchase agreement Research and development expenses: Employees' bonus Officers’ bonus Total stock-based compensation expense Significant Accounting Policies And Recent Accounting Pronouncements Detail Narrative Purchase of treasury stock, value Common Shares equivalents to convertible notes payable underlying shares and unvested restricted stock Useful life Purchased Patent Rights Less: Accumulated amortization Patent costs - net Amortization period Amortization expense Estimated remaining useful lives of the assets Estimated annual amortization expense Accrued Expenses Details Accrued research and development consulting fees Accrued rent (Note 8) - related parties Accrued interest (Note 9) - related parties Total Accrued Salaries And Payroll Taxes - Related Parties And Other Details Accrued salaries - related parties Accrued payroll taxes - related parties Accrued salaries - employees Withholding tax Total Annual salary Annual increment percentage Commitments And Contingencies Details Year ending June 30, 2018 2019 Total minimum payments Operating leases, rental expense Lease term Lease expiry date Rent expense Monthly payment on lease by officers Area used by officers Lease commencement date Total Contractual Commitments Rental income Rent payables Accrued research and development expenses Accrued interest - related parties Principal balance of demand notes Additional loan balance Interest rate Common stock price per share Equity Incentive shares Options exercisable Closing bid price per share Percentage closing bid price Equity incentive options exercisable period Number of Outstanding, Beginning Balance Granted Forfeited/expired Number of Outstanding, Ending Balance Number of Outstanding, Exercisable Weighted Average Exercise Price, Beginning Balance Granted Forfeited/expired Weighted Average Exercise Price, Ending Balance Weighted Average Exercise Price, Exercisable Weighted average remaining contractual life (Years), Outstanding, Beginning Balance Weighted average remaining contractual life (Years), Outstanding, Ending Balance Weighted average remaining contractual life (Years), Exercisable Aggregate intrinsic value, Beginning Balance Aggregate intrinsic value, Ending Balance Aggregate intrinsic value, Exercisable Expected term (in years) Expected stock price volatility Risk-free interest rate Expected dividend yield Equity Incentive Plans Stock-based Compensation Exercise Of Options And Warrants Outstanding Details 2 Total shares granted Total shares vested Total shares forfeited Total shares granted Total shares vested Total shares forfeited Scheduled vesting - restricted stock Equity Components [Axis] Transaction Type [Axis] Exercise price Exercisable period Common stock shares reserved and issuance Restricted stock Stock option vested, description Common stock closing price Stock based compensation Stock option expenses Restricted stock awards Stock based compensation description Stock options to purchase shares Options vested or expected to vest Stock options to purchase shares, value Stock option exercise price Stock issued, Shares Stock issued, Value Annual salary Proceeds from exercise of rights Shares issued upon exercise of warrants Stock options forfeited Restricted stock fofeited Common stock shares withheld Common stock shares issued Subscription receivable outstanding Shares issued Treasury stock, shares outstanding Cumulative cost of shares Unrecognized compensation cost related to unvested restricted stock-based compensation Compensation cost not yet recognized, period for recognition Expected share based compensation expenses Common stock per shares Common stock value Derivative Instrument [Axis] Term of the purchase agreement Deferred offering costs Common stock shares issued Common stock shares sold Proceeds from issuance of common stock Value of common stock shares issuable under agreement Amortization of commitment fee, Amount amortized Amortization recorded to additional paid in capital Available shares of common stock Common stock purchase agreement Sale of common stock Ac crude Expense To Related Party [Text Block] Accrued Consulting Fee, Current Accrued research and development expenses. Accrued Salaries Due To Related Parties, Current Additions to property plant and equipment. Agreement [Axis] Clinical Studies. Consultant. Kard Scientific [Member] Patents Four [Member] Patents Three [Member] Patents Two [Member] Schedule Of Accrued Salaries and Payroll Taxes [Table Text Block] Withholding Tax Related Parties Year 2026. Year 2027. Year 2028. Year 2029. Finite Lived Intangible Assets Amortization Expense Rolling For Future Year Aspire Capital Fund Llc [Member] Common stock purchase agreement two. Common Stock Purchase Agreement [Member] Common stock purchase agreement. Monthly payment on lease by officers. Area used by officers. Assets, Current Other Assets Assets Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts and Other Receivables AdditionsToPropertyPlantAndEquipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash, Period Increase (Decrease) Accrued Liabilities Capital Leases, Future Minimum Payments Due Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodVestedWeightedAverage AnnualSalaries AgreementAxis PatentsFourMember CommonStockPurchaseAgreementTwoMember CommonStockPurchaseAgreementMember CommonStockPurchaseAgreementOneMember